Quarter Period Statement Of Income

Carna Biosciences, Inc. - Filing #7313273

Concept 2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
Quarter period statement of income
Statement of income
Net sales
315,642,000 JPY
JPY
315,642,000 JPY
500,570,000 JPY
500,570,000 JPY
JPY
Cost of sales
82,630,000 JPY
82,684,000 JPY
Gross profit (loss)
233,012,000 JPY
417,886,000 JPY
Selling, general and administrative expenses
1,328,013,000 JPY
1,281,582,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-1,095,000,000 JPY
-1,070,639,000 JPY
-24,361,000 JPY
-863,696,000 JPY
169,321,000 JPY
-1,033,017,000 JPY
Non-operating income
Interest income
2,543,000 JPY
84,000 JPY
Dividend income
219,000 JPY
211,000 JPY
Non-operating income
32,877,000 JPY
2,430,000 JPY
Non-operating expenses
Interest expenses
1,726,000 JPY
1,695,000 JPY
Non-operating expenses
25,033,000 JPY
7,139,000 JPY
Ordinary profit (loss)
-1,087,156,000 JPY
-868,405,000 JPY
Extraordinary losses
Impairment losses
4,228,000 JPY
984,000 JPY
Extraordinary losses
4,228,000 JPY
984,000 JPY
Profit (loss) before income taxes
-1,091,384,000 JPY
-869,389,000 JPY
Income taxes - current
2,785,000 JPY
16,275,000 JPY
Income taxes - deferred
-52,000 JPY
-56,000 JPY
Income taxes
2,733,000 JPY
16,218,000 JPY
Profit (loss)
-1,094,118,000 JPY
-885,608,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.